Mumbai-based healthcare AI startup Qure.ai on Thursday announced that it had raised $16 million in funding from Sequoia India and MassMutual Ventures Southeast Asia. The company uses AI to predict and analyse medical imaging to help healthcare providers in delivering exceptional care. Qure.ai offers CE certified solutions such as chest X-rays, tuberculosis screening, and head CT scans. These solutions detect critical abnormalities in a head CT scan, cranial fractures, infarcts, among others.

Equipped with robust solutions, Qure.ai has impacted over 600,000 lives by using AI on over seven million scans. The company boasts of expediting the process of interpreting scans within seconds, thereby reducing the cost of treatment while determining anomalies that can be unseen by doctors.

“The team has taken the research stage to actually impacting patient lives across more than 200 locations in 20 countries. Our products assist doctors in providing life-saving treatments, even in remote locations. This funding round will enable us to further accelerate our mission of delivering accessible and affordable healthcare for all,” says Prashant Warier, Co-founder and CEO, Qure.ai. “We have a brilliant team that’s committed to making healthcare accessible and affordable through AI. I am excited about the open research approach that Qure.ai has adopted.”

Founded in 2016, the company has quickly gained traction in the health tech landscape as penetration of AI in this domain is risky. Unlike in other sectors, a wrong prediction my AI could be fatal for patients. Thus, organisations have to ensure that they remove the flaws of AI such as bias and inaccurate predictions.

Besides, due to privacy issues in processing patients’ data, organisations limit themselves to serving the landscape. However, various companies are now getting into the market while eliminating the risk of AI. And Qure.ai is one of them that is making a difference in healthcare through their solutions.